Establishing risk of human experimentation with drugs: lessons from TGN1412
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the revised guideline puts more emphasis on the ongoing determination of dose/exposure-effect relations of the drug, primarily because this is a safer approach for compounds carrying a higher uncertainty [5,15].”
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Phan, G. Q., Yang, J. C., Sherry, R. M., Hwu, P., Topalian, S. L., Schwartzentruber, D. J., Restifo, N. P., Haworth, L. R., Seipp, C. A., Freezer, L. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533209100 · Cited by 1,575
Beck, K. E., Blansfield, J. A., Tran, K. Q., Feldman, A. L., Hughes, M. S., Royal, R. E., Kammula, U. S., Topalian, S. L., Sherry, R. M., Kleiner, D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5716 · Cited by 833
Blansfield, J. A., Beck, K. E., Tran, K., Yang, J. C., Hughes, M. S., Kammula, U. S., Royal, R. E., Topalian, S. L., Haworth, L. R., Levy, C., et al. (2005) · Journal of Immunotherapy · doi:10.1097/01.cji.0000178913.41256.06 · Cited by 355
Regulation of Immune Responses by T Cells
Jiang, H., & Chess, L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055446 · Cited by 253
Kuppner, M. C., Gastpar, R., Gelwer, S., Nössner, E., Ochmann, O., Scharner, A., & Issels, R. D. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200105)31:5<1602::aid-immu1602>3.0.co;2-w · Cited by 213
Lühder, F., Huang, Y., Dennehy, K. M., Guntermann, C., Müller, I., Winkler, E., Kerkau, T., Ikemizu, S., Davis, S. J., Hanke, T., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021024 · Cited by 193
Crystal structure of a soluble CD28-Fab complex
Evans, E. J., Esnouf, R. M., Manso-Sancho, R., Gilbert, R. J. C., James, J. R., Yu, C., Fennelly, J. A., Vowles, C., Hanke, T., Walse, B., et al. (2005) · Nature Immunology · doi:10.1038/ni1170 · Cited by 180
Protecting Research Subjects — The Crisis at Johns Hopkins
Steinbrook, R. (2002) · New England Journal of Medicine · doi:10.1056/nejm200202283460924 · Cited by 169
Cited by
How to increase value and reduce waste when research priorities are set
Chalmers, I., Bracken, M. B., Djulbegovic, B., Garattini, S., Grant, J., Gülmezoglu, A. M., Howells, D. W., Ioannidis, J. P. A., & Oliver, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62229-1 · Cited by 1,436
The safety and side effects of monoclonal antibodies
Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A., & George, A. J. T. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3003 · Cited by 1,144
Why animal studies are often poor predictors of human reactions to exposure
Bracken, M. B. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.08k033 · Cited by 362
Stebbings, R., Findlay, L., Edwards, C., Eastwood, D., Bird, C., North, D., Mistry, Y., Dilger, P., Liefooghe, E., Cludts, I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.5.3325 · Cited by 316
“Moreover, macaque CD28 differs from human CD28 in three transmembrane residues and it has been suggested that this could alter associations with molecular partners (13).”
BackgroundIssues in the Registration of Clinical Trials
Zarin, D. A., Ide, N. C., Tse, T., Harlan, W. R., West, J. C., & Lindberg, D. A. B. (2007) · JAMA · doi:10.1001/jama.297.19.2112 · Cited by 222
“For example, a recent “first in human” study of a new immune modulator, known as TGN1412, had catastrophic effects on 6 volunteers; their participation should, at a minimum, inform future related research.(50) However, without knowing the identity of this agent, it would not be possible to warn investigators, IRB memb…”
Background
Metadata
- Authors
- Kenter, M., & Cohen, A.
- Affiliations
- Centre for Human Drug Research (NL)
- Corresponding author
- Cohen, AF
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 368
- Issue
- 9544
- Pages
- 1387-1391
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2137571650
- Cited by
- 153
- References
- 24
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 1 · 2020: 9 · 2019: 10 · 2018: 8 · 2017: 6 · 2016: 14 · 2015: 4 · 2014: 8 · 2013: 6 · 2012: 3
- FWCI
- 18.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- TGN1412, healthy volunteers, drug safety, adverse drug reactions, regulatory guidelines
- MeSH terms
- Amino Acid Sequence, Animals, Antibodies, Monoclonal, Biotechnology, Clinical Trials as Topic, Humans, Human Experimentation, Interleukins, Macaca mulatta, Molecular Sequence Data, Risk Assessment, Antibodies, Monoclonal, Humanized
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Establishing risk of human experimentation with drugs: lessons from TGN1412. https://app.cochat.ai/papers/10.1016/s0140-6736(06)69562-7
- The paper
- Kenter, M., & Cohen, A. (2006). Establishing risk of human experimentation with drugs: lessons from TGN1412. The Lancet. https://doi.org/10.1016/s0140-6736(06)69562-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.